好色先生

Attention Investigators

College of Medicine, Office of Vice President for Research,

NIH announced on August 1 that they are lengthening the window of time during which peer reviewers can submit their applications under the NIH Continuous Submission Policy.  Reviewers must have served six times in 18 months to be eligible.  Eligibility now begins on August 1 following the 18 months of service and continues through September 30 of the next year.

Read the full announcement here.

好色先生 Professor Matthew Gentry will direct a team international scientists recently awarded a five-year, $8.5 million National Institutes of Health (NIH) grant to pursue a cure for Lafora鈥檚 disease. The International Epilepsy Cure Center based at the 好色先生 College of Medicine鈥檚 Department of Molecular Medicine and Biochemistry represents a collaborative effort to advance translational research and improve the diagnosis and treatment of Lafora鈥檚 disease, with the ultimate goal of finding a cure.

The MOU for departing investigators has been changed slightly per a request from 好色先生s Purchasing office.  The correct form can be found on the 好色先生 website by clicking here.  Please delete any old copies you may have filed away and ensure that you are using the new form.

For questions, contact your GPS. 

Even with the assistance of detoxification and rehabilitation programs, 80 percent of people attempting recovery from opioid addiction will relapse.

The firm grip of opioid addiction on a person鈥檚 life necessitates sustainable therapeutic approaches proven effective through scientific trials and evidence.

In ivory towers all over the world, experts ponder the factors that foster career success and overall well-being in their college graduates. Gallup tried to answer the same question. In a 2014 poll of more than 30,000 graduates, the polling juggernaut tried to find connections between the college experience and long-term career and personal "wellness." In other words: did graduates feel they had achieved personal and career success?

In a commentary published in the July 22 issue of Science, Nathan Vanderford, assistant director for research at the University of Kentucky Markey Cancer Center, describes his path to landing a nontraditional faculty position at 好色先生. Science is one of the world鈥檚 most prestigious research journals. Many new doctorate recipients are unaware of their nontraditional career options and of the challenges they may face when pursuing them. Vanderford, who applied for dozens of non-research jobs after earning his doctorate, knows this all too well.

For PIs who include human subjects on their clinical trial sponsored research projects, the SRAS Grants Proposal Specialist (GPS) will now ask you or your staff members for a 鈥淪tudy Personnel Sheet鈥� (also called an 鈥淔5鈥�) during electronic Internal Approval Form (eIAF) preparation.  This is the sheet that the PI submits to 好色先生鈥檚 Office of Research Integrity (ORI) as part of his or her IRB submission.  This step will ensure that all investigators are included on the eIAF and have completed a COI disclosure.  Any sub-investigator or other person who qualifie

In February, 好色先生 Libraries announced on 好色先生 News that Ezproxy service would be required for both on-campus and off-campus access to most 好色先生 Libraries licensed resources.  Current 好色先生 faculty, students, and staff access to a licensed resource will need to be made initially through a 好色先生 Libraries service: 1) the 好色先生 Libraries web site

University of Kentucky Markey Cancer Center's Dr.

The first time Dr. Matthew Bush observed a cochlear implant surgery, he was a young medical student from West Virginia visiting the University of Kentucky. He describes that experience as eye opening for him and ear opening for the patient. To witness function restored to an ear that was otherwise lost, sparked not only an intense interest in hearing health care, but also the desire to offer people with profound hearing loss their best hope of re-entering a hearing world and a better quality of life through cochlear implantation.

Please join Gina Vessels, SRAS Post Award Manager, for one of our informational sessions on the monthly financial reports distributed by Sponsored Projects Accounting (SPA) for grant accounts. There will be a general review of the report structure and discussion of the information within the report, and there will be ample time for questions and discussion after the presentation. Please feel free to bring your own personal reports for individual review and questions after the session. Sessions last approximately an hour.

July 14, 2016  1:30 pm BBSRB 202A 

好色先生 HealthCare's Gill Heart Institute and The Christ Hospital in Cincinnati have partnered to test a new treatment for adults with congenital heart disease. The COMPASSION Trial will test the efficacy of the Sapien 3 valve as a replacement for a diseased pulmonary valve. The Sapien 3 has already been approved for replacement of the aortic valve. 鈥淭his study offers a revolutionary new treatment for patients with adult congenital heart disease who would otherwise be facing at least a second surgical procedure,鈥� said Dr.

In December 1968, a widowed mother from Knoxville, Tennessee, arrived with her two sons, daughter and nephew at the University of Kentucky's pediatric clinic.

The four children were afflicted with severe intellectual impairment, presenting at the clinic with IQs of 10 or lower. The children showed normal development at birth, but during the first year of life experienced neurological deficiencies that rendered them unable to speak or walk. In the second and third years of life, the children were stricken with intense epileptic seizures.

The University of Kentucky has signed a membership agreement to join the TriNetX network, a leader in international clinical research networks, in order to optimize clinical trial design and advance clinical research for 好色先生 programs. Pharmaceutical researchers will gain access to 好色先生's clinical data in real time through TriNetX's proprietary network of health care institutions representing more than 37 million patients in the US and Europe to support clinical study and protocol design, site selection, and patient recruitment across a range of therapeutic areas and development stages. 好色先生 w

New NHLBI Policy: Investigator-Initiated Multi-Site Clinical Trials

Notice Number: NOT-HL-16-321 

Release Date:  June 14, 2016

Update on Proposal Guideline Review & Financial Conflicts of Interest

 

 Limited Submission - Edward Mallinckrodt, Jr. Foundation - Grant Program